These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11267473)

  • 1. Long-term prednisolone withdrawal after pancreas and kidney transplantation in patients treated with ATG, tacrolimus, and mycophenolate mofetil.
    Kahl A; Bechstein WO; Lorenz F; Steinberg J; Pohle C; Kampf D; Müller A; Settmacher U; Neuhaus P; Frei U
    Transplant Proc; 2001; 33(1-2):1694-5. PubMed ID: 11267473
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-center experience of 60 consecutive simultaneous pancreas-kidney transplants using mycophenolate mofetil and tacrolimus as primary maintenance immunotherapy.
    Kaufman DB; Leventhal JR; Stuart J; Parker M; Abecassis M; Fryer JP; Stuart FP
    Transplant Proc; 1999; 31(1-2):615-6. PubMed ID: 10083261
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction.
    Burke GW; Ciancio G; Alejandro R; Roth D; Ricordi C; Tzakis A; Miller J
    Transplant Proc; 1998 Jun; 30(4):1544-5. PubMed ID: 9636627
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term results of pancreas transplantation under tacrolius immunosuppression.
    Jordan ML; Shapiro R; Gritsch HA; Egidi F; Khanna A; Vivas CA; Scantlebury VP; Fung JJ; Starzl TE; Corry RJ
    Transplantation; 1999 Jan; 67(2):266-72. PubMed ID: 10075592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
    Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR
    Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
    [No Abstract]   [Full Text] [Related]  

  • 6. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
    Schulz T; Papapostolou G; Schenker P; Kapischke M
    Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients.
    el-Ghoroury M; Hariharan S; Peddi VR; Munda R; Schroeder TJ; Demmy AM; Alexander JW; First MR
    Transplant Proc; 1997; 29(1-2):649-51. PubMed ID: 9123461
    [No Abstract]   [Full Text] [Related]  

  • 8. Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression.
    Jordan ML; Chakrabarti P; Luke PP; Shapiro R; Vivas CA; Scantlebury VP; Hakala TR; Fedorek S; Corry RJ
    Transplant Proc; 2001; 33(1-2):1655. PubMed ID: 11267456
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation.
    Hariharan S; Peddi VR; Munda R; Demmy AM; Schroeder TJ; Alexander JW; First MR
    Transplant Proc; 1997; 29(1-2):652-3. PubMed ID: 9123462
    [No Abstract]   [Full Text] [Related]  

  • 10. A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients.
    Stratta RJ; Taylor RJ; Weide LG; Sindhi R; Sudan D; Castaldo P; Cushing KA; Frisbie K; Radio SJ
    Transplant Proc; 1996 Apr; 28(2):917-8. PubMed ID: 8623461
    [No Abstract]   [Full Text] [Related]  

  • 11. Early steroid withdrawal in solitary pancreas transplantation results in equivalent graft and patient survival compared with maintenance steroid therapy.
    Vessal G; Wiland AM; Philosophe B; Fink JC; Weir MR; Klassen DK
    Clin Transplant; 2007; 21(4):491-7. PubMed ID: 17645708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreas after kidney transplantation: HLA mismatch does not preclude success.
    Basadonna GP; Auersvald LA; Oliveira SC; Friedman AL; Lorber MI
    Transplant Proc; 1997; 29(1-2):667. PubMed ID: 9123470
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus in solid organ transplantation: an update.
    Shapiro R
    Transplant Proc; 1999 Sep; 31(6):2203-5. PubMed ID: 10500545
    [No Abstract]   [Full Text] [Related]  

  • 16. Ten-year survival after simultaneous pancreas/kidney transplantation with bladder drainage and tacrolimus-based immunosuppression.
    Burke GW; Ciancio G; Olson L; Roth D; Miller J
    Transplant Proc; 2001; 33(1-2):1681-3. PubMed ID: 11267467
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody induction therapy in pancreas transplantation.
    Gruessner RW
    Transplant Proc; 1998 Jun; 30(4):1556-9. PubMed ID: 9636632
    [No Abstract]   [Full Text] [Related]  

  • 18. Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation.
    Lo A; Stratta RJ; Alloway RR; Egidi MF; Shokouh-Amiri MH; Grewal HP; Gaber AO
    Transplant Proc; 2001; 33(1-2):1701-3. PubMed ID: 11267477
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycophenolate mofetil/prednisolone/single-shot ATG with tacrolimus or cyclosporine in pancreas/kidney transplantation: first results of an ongoing prospective randomized trial.
    Schulz T; Konzack J; Büsing M
    Transplant Proc; 1999; 31(1-2):591-2. PubMed ID: 10083251
    [No Abstract]   [Full Text] [Related]  

  • 20. Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin.
    Schulz T; Martin D; Heimes M; Klempnauer J; Buesing M
    Transplant Proc; 1998 Jun; 30(4):1533-5. PubMed ID: 9636623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.